Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.46 is 28% below its 5-year average of 6.19, near the low end of its 5-year range (2.28–9.90).
As of the fiscal period ended Tuesday, June 30, 2026. 36.22% below its 12-month average of 6.99.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.46.
QUICK RATIO (ACID-TEST)
4.46
QUICK RATIO (ACID-TEST) AVG TTM
6.99
QUICK RATIO (ACID-TEST) AVG 3Y
5.82
QUICK RATIO (ACID-TEST) AVG 5Y
6.19
QUICK RATIO (ACID-TEST) AVG 10Y
5.04
QUICK RATIO (ACID-TEST) AVG 15Y
5.60
QUICK RATIO (ACID-TEST) AVG 20Y
4.58
CURRENT VS TTM AVG
-36.22%
CURRENT VS 3Y AVG
-23.44%
CURRENT VS 5Y AVG
-27.97%
CURRENT VS 10Y AVG
-11.58%
CURRENT VS 15Y AVG
-20.46%
CURRENT VS 20Y AVG
-2.67%
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+33.04%
vs the sector median at left
EyePoint Pharmaceuticals, Inc.
Market Cap
$262.00M
Quick Ratio (Acid-Test)
4.46
TTM Avg
6.99
3Y Avg
5.82
5Y Avg
6.19
Market Cap
$261.24M
Quick Ratio (Acid-Test)
24.26
TTM Avg
16.09
3Y Avg
10.56
5Y Avg
7.83
Market Cap
$261.28M
Quick Ratio (Acid-Test)
7.68
TTM Avg
7.37
3Y Avg
6.66
5Y Avg
5.96
Market Cap
$263.41M
Quick Ratio (Acid-Test)
15.82
TTM Avg
24.04
3Y Avg
14.70
5Y Avg
12.06
Market Cap
$258.85M
Quick Ratio (Acid-Test)
11.02
TTM Avg
6.66
3Y Avg
6.10
5Y Avg
6.28
Market Cap
$258.73M
Quick Ratio (Acid-Test)
16.00
TTM Avg
13.11
3Y Avg
8.33
5Y Avg
7.81
Market Cap
$264.25M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.68M
Quick Ratio (Acid-Test)
1.95
TTM Avg
3.31
3Y Avg
3.54
5Y Avg
4.00
Market Cap
$257.37M
Quick Ratio (Acid-Test)
0.93
TTM Avg
1.36
3Y Avg
5.78
5Y Avg
8.29
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $262.00M | 4.46 | 6.99 | 5.82 | 6.19 |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | 24.26 | 16.09 | 10.56 | 7.83 |
| OraSure Technologies, Inc. (OSUR)vs › | $261.28M | 7.68 | 7.37 | 6.66 | 5.96 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $263.41M | 15.82 | 24.04 | 14.70 | 12.06 |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $258.85M | 11.02 | 6.66 | 6.10 | 6.28 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $258.73M | 16.00 | 13.11 | 8.33 | 7.81 |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| Treace Medical Concepts, Inc. (TMCI)vs › | $264.68M | 1.95 | 3.31 | 3.54 | 4.00 |
| AC Immune S.A. (ACIU)vs › | $257.37M | 0.93 | 1.36 | 5.78 | 8.29 |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $256.77M | 13.89 | 8.37 | 7.38 | 15.00 |
Quick Ratio
4.46
Excludes inventory
Current Ratio
4.50
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.46 |
| 2026-03-31 | 6.63 |
| 2025-12-31 | 8.83 |
| 2025-09-30 | 7.11 |
| 2025-06-30 | 7.91 |
| 2025-03-31 | 7.79 |
| 2024-12-31 | 7.77 |
| 2024-09-30 | 5.45 |
| 2024-06-30 | 4.69 |
| 2024-03-31 | 5.01 |
| 2023-12-31 | 5.39 |
| 2023-09-30 | 2.28 |
| 2023-06-30 | 2.36 |
| 2023-03-31 | 5.21 |
| 2022-12-31 | 4.92 |
| 2022-09-30 | 5.50 |
| 2022-06-30 | 6.07 |
| 2022-03-31 | 6.77 |
| 2021-12-31 | 9.90 |
| 2021-09-30 | 6.88 |
| 2021-06-30 | 9.01 |
| 2021-03-31 | 11.44 |
| 2020-12-31 | 3.88 |
| 2020-09-30 | 3.40 |
| 2020-06-30 | 3.76 |
| 2020-03-31 | 4.50 |
| 2019-12-31 | 3.44 |
| 2019-09-30 | 4.29 |
| 2019-06-30 | 5.31 |
| 2019-03-31 | 1.93 |
| 2018-12-31 | 2.21 |
| 2018-09-30 | 2.57 |
| 2018-06-30 | 1.84 |
| 2018-03-31 | 0.83 |
| 2017-12-31 | 3.21 |
| 2017-09-30 | 2.93 |
| 2017-06-30 | 3.35 |
| 2017-03-31 | 3.33 |
| 2016-12-31 | 3.76 |
| 2016-09-30 | 4.85 |
| 2016-06-30 | 5.88 |
| 2016-03-31 | 8.64 |
| 2015-12-31 | 5.63 |
| 2015-09-30 | 8.41 |
| 2015-06-30 | 8.91 |
| 2015-03-31 | 14.91 |
| 2014-12-31 | 16.43 |
| 2014-09-30 | 17.60 |
| 2014-06-30 | 9.10 |
| 2014-03-31 | 9.87 |
| 2013-12-31 | 8.01 |
| 2013-09-30 | 6.69 |
| 2013-06-30 | 3.77 |
| 2013-03-31 | 5.66 |
| 2012-12-31 | 8.07 |
| 2012-09-30 | 5.46 |
| 2012-06-30 | 5.02 |
| 2012-03-31 | 6.91 |
| 2011-12-31 | 7.54 |
| 2011-09-30 | 5.58 |
| 2011-06-30 | 5.04 |
| 2011-03-31 | 16.31 |
| 2010-12-31 | 0.00 |
| 2010-09-30 | 7.34 |
| 2010-06-30 | 6.49 |
| 2010-03-31 | 1.36 |
| 2009-12-31 | 1.51 |
| 2009-09-30 | 0.98 |
| 2009-06-30 | 0.93 |
| 2009-03-31 | 0.85 |
| 2008-12-31 | 0.83 |
| 2008-09-30 | 0.97 |
| 2008-06-30 | 1.02 |
| 2008-03-31 | 1.41 |
| 2007-12-31 | 1.17 |
| 2007-09-30 | 1.50 |
| 2007-06-30 | 0.29 |
| 2007-03-31 | 0.00 |
| 2006-12-31 | 0.26 |
| 2006-09-30 | 0.00 |
| 2006-06-30 | 0.71 |
| 2006-05-11 | 0.00 |
| 2005-12-31 | 0.00 |
| 2005-11-30 | 0.00 |
| 2005-06-30 | 6.80 |
| 2005-03-31 | 0.00 |
| 2004-12-31 | 0.00 |
| 2004-09-30 | 0.00 |
| 2004-06-30 | 16.37 |
| 2004-03-31 | 0.00 |
| 2003-12-31 | 0.00 |
| 2003-09-30 | 0.00 |
| 2003-06-30 | 1.50 |
| 2003-03-31 | 0.00 |
| 2002-12-31 | 0.00 |
| 2002-09-30 | 0.00 |